Preparation of 123-iodine labeled glucosamine derivative and investigation of its biological properties

M. S. Larkina, A. S. Semenov, R. V. Zelchan, E. V. Podrezova, O. D. Bragina, M. S. Yusubov, V. S. Skuridin, V. I. Chernov, M. V. Belousov, M. S. Timofeev

Research output: Contribution to journalArticle

Abstract

Search and synthesis of glucose derivatives for nuclear medicine is of great current interest. Being a promising analogue of glucose, D-glucosamine iodine labeled glucose derivatives can be applied in rheumatoid arthritis radionuclide diagnostics and therapy as a radiopharmaceutical. The purpose of the study. Synthesis of a new iodine labeled D-glucosamine derivative; development of the iodine-123 labeling method and the obtained glucose derivative biostudy. Materials and methods. Synthesis of 2-N-(6-iodohexanoyl)-D-glucosamine was carried out through established techniques in organic chemistry. Infrared spectroscopy and nuclear magnetic resonance spectroscopy were used to establish the test compound structure. Isotope change between iodine-127 and iodine-123 of glucosamine derivative was conducted using the heating of mix of the compound and Na123I in acetone. The radio-TLC method was applied to estimate the radiochemical purity of 2-N- (6-iod-123-hexanoyl) -D-glucosamine. The safe application and test of drug pharmacokinetic parameters study was performed on intact Wistar male rats. Results. An original 2-N-(6-iodohexanoyl)-D-glucosamine synthesis method was proposed. According to the method, an intermediate synthesis succimide-1-yl 6-iodohexanoate was obtained by the cyclohexanone oxidative cleavage reaction. The radiochemical purity of 2-N-(6-iodo-123-hexanoyl)-D-glucosamine was more than 97%. Conclusion. 2-N-(6-iodohexanoyl)-D-glucosamine was synthesized and iodine-123 labeled. When investigating the proposed radiopharmaceutical safety and pharmacokinetics, it was shown the drug lacks acute toxicity through intravenous injection and is excreted renally by glomerular filtration.

Original languageEnglish
Pages (from-to)102-111
Number of pages10
JournalBulletin of Siberian Medicine
Volume17
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint

Glucosamine
Iodine
Glucose
Radiopharmaceuticals
Pharmacokinetics
Organic Chemistry
Nuclear Medicine
Acetone
Radio
Intravenous Injections
Radioisotopes
Isotopes
Pharmaceutical Preparations
Heating
Wistar Rats
Rheumatoid Arthritis
Spectrum Analysis
Magnetic Resonance Spectroscopy
Safety

Keywords

  • 2-N-(6-iodohexanoyl)-D-glucosamine
  • Cyclohexanone
  • D-glucosamine
  • Iodine-123
  • RFP

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Preparation of 123-iodine labeled glucosamine derivative and investigation of its biological properties. / Larkina, M. S.; Semenov, A. S.; Zelchan, R. V.; Podrezova, E. V.; Bragina, O. D.; Yusubov, M. S.; Skuridin, V. S.; Chernov, V. I.; Belousov, M. V.; Timofeev, M. S.

In: Bulletin of Siberian Medicine, Vol. 17, No. 1, 01.01.2018, p. 102-111.

Research output: Contribution to journalArticle

@article{7fda8957b7c94817b88217255b0e11a7,
title = "Preparation of 123-iodine labeled glucosamine derivative and investigation of its biological properties",
abstract = "Search and synthesis of glucose derivatives for nuclear medicine is of great current interest. Being a promising analogue of glucose, D-glucosamine iodine labeled glucose derivatives can be applied in rheumatoid arthritis radionuclide diagnostics and therapy as a radiopharmaceutical. The purpose of the study. Synthesis of a new iodine labeled D-glucosamine derivative; development of the iodine-123 labeling method and the obtained glucose derivative biostudy. Materials and methods. Synthesis of 2-N-(6-iodohexanoyl)-D-glucosamine was carried out through established techniques in organic chemistry. Infrared spectroscopy and nuclear magnetic resonance spectroscopy were used to establish the test compound structure. Isotope change between iodine-127 and iodine-123 of glucosamine derivative was conducted using the heating of mix of the compound and Na123I in acetone. The radio-TLC method was applied to estimate the radiochemical purity of 2-N- (6-iod-123-hexanoyl) -D-glucosamine. The safe application and test of drug pharmacokinetic parameters study was performed on intact Wistar male rats. Results. An original 2-N-(6-iodohexanoyl)-D-glucosamine synthesis method was proposed. According to the method, an intermediate synthesis succimide-1-yl 6-iodohexanoate was obtained by the cyclohexanone oxidative cleavage reaction. The radiochemical purity of 2-N-(6-iodo-123-hexanoyl)-D-glucosamine was more than 97{\%}. Conclusion. 2-N-(6-iodohexanoyl)-D-glucosamine was synthesized and iodine-123 labeled. When investigating the proposed radiopharmaceutical safety and pharmacokinetics, it was shown the drug lacks acute toxicity through intravenous injection and is excreted renally by glomerular filtration.",
keywords = "2-N-(6-iodohexanoyl)-D-glucosamine, Cyclohexanone, D-glucosamine, Iodine-123, RFP",
author = "Larkina, {M. S.} and Semenov, {A. S.} and Zelchan, {R. V.} and Podrezova, {E. V.} and Bragina, {O. D.} and Yusubov, {M. S.} and Skuridin, {V. S.} and Chernov, {V. I.} and Belousov, {M. V.} and Timofeev, {M. S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.20538/1682-0363-2018-1-102-111",
language = "English",
volume = "17",
pages = "102--111",
journal = "Bulletin of Siberian Medicine",
issn = "1682-0363",
publisher = "Siberian State Medical University",
number = "1",

}

TY - JOUR

T1 - Preparation of 123-iodine labeled glucosamine derivative and investigation of its biological properties

AU - Larkina, M. S.

AU - Semenov, A. S.

AU - Zelchan, R. V.

AU - Podrezova, E. V.

AU - Bragina, O. D.

AU - Yusubov, M. S.

AU - Skuridin, V. S.

AU - Chernov, V. I.

AU - Belousov, M. V.

AU - Timofeev, M. S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Search and synthesis of glucose derivatives for nuclear medicine is of great current interest. Being a promising analogue of glucose, D-glucosamine iodine labeled glucose derivatives can be applied in rheumatoid arthritis radionuclide diagnostics and therapy as a radiopharmaceutical. The purpose of the study. Synthesis of a new iodine labeled D-glucosamine derivative; development of the iodine-123 labeling method and the obtained glucose derivative biostudy. Materials and methods. Synthesis of 2-N-(6-iodohexanoyl)-D-glucosamine was carried out through established techniques in organic chemistry. Infrared spectroscopy and nuclear magnetic resonance spectroscopy were used to establish the test compound structure. Isotope change between iodine-127 and iodine-123 of glucosamine derivative was conducted using the heating of mix of the compound and Na123I in acetone. The radio-TLC method was applied to estimate the radiochemical purity of 2-N- (6-iod-123-hexanoyl) -D-glucosamine. The safe application and test of drug pharmacokinetic parameters study was performed on intact Wistar male rats. Results. An original 2-N-(6-iodohexanoyl)-D-glucosamine synthesis method was proposed. According to the method, an intermediate synthesis succimide-1-yl 6-iodohexanoate was obtained by the cyclohexanone oxidative cleavage reaction. The radiochemical purity of 2-N-(6-iodo-123-hexanoyl)-D-glucosamine was more than 97%. Conclusion. 2-N-(6-iodohexanoyl)-D-glucosamine was synthesized and iodine-123 labeled. When investigating the proposed radiopharmaceutical safety and pharmacokinetics, it was shown the drug lacks acute toxicity through intravenous injection and is excreted renally by glomerular filtration.

AB - Search and synthesis of glucose derivatives for nuclear medicine is of great current interest. Being a promising analogue of glucose, D-glucosamine iodine labeled glucose derivatives can be applied in rheumatoid arthritis radionuclide diagnostics and therapy as a radiopharmaceutical. The purpose of the study. Synthesis of a new iodine labeled D-glucosamine derivative; development of the iodine-123 labeling method and the obtained glucose derivative biostudy. Materials and methods. Synthesis of 2-N-(6-iodohexanoyl)-D-glucosamine was carried out through established techniques in organic chemistry. Infrared spectroscopy and nuclear magnetic resonance spectroscopy were used to establish the test compound structure. Isotope change between iodine-127 and iodine-123 of glucosamine derivative was conducted using the heating of mix of the compound and Na123I in acetone. The radio-TLC method was applied to estimate the radiochemical purity of 2-N- (6-iod-123-hexanoyl) -D-glucosamine. The safe application and test of drug pharmacokinetic parameters study was performed on intact Wistar male rats. Results. An original 2-N-(6-iodohexanoyl)-D-glucosamine synthesis method was proposed. According to the method, an intermediate synthesis succimide-1-yl 6-iodohexanoate was obtained by the cyclohexanone oxidative cleavage reaction. The radiochemical purity of 2-N-(6-iodo-123-hexanoyl)-D-glucosamine was more than 97%. Conclusion. 2-N-(6-iodohexanoyl)-D-glucosamine was synthesized and iodine-123 labeled. When investigating the proposed radiopharmaceutical safety and pharmacokinetics, it was shown the drug lacks acute toxicity through intravenous injection and is excreted renally by glomerular filtration.

KW - 2-N-(6-iodohexanoyl)-D-glucosamine

KW - Cyclohexanone

KW - D-glucosamine

KW - Iodine-123

KW - RFP

UR - http://www.scopus.com/inward/record.url?scp=85049973601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049973601&partnerID=8YFLogxK

U2 - 10.20538/1682-0363-2018-1-102-111

DO - 10.20538/1682-0363-2018-1-102-111

M3 - Article

AN - SCOPUS:85049973601

VL - 17

SP - 102

EP - 111

JO - Bulletin of Siberian Medicine

JF - Bulletin of Siberian Medicine

SN - 1682-0363

IS - 1

ER -